Pune, Oct. 21, 2022 (GLOBE NEWSWIRE) -- The global neurothrombectomy devices market is expected to clock US$ 1249.42 million by 2030. The global neurothrombectomy devices market is primarily driven by chronic diseases such as high blood pressure, high cholesterol, cardiovascular diseases, and the prevalence of ischemic stroke. Furthermore, technological advancement and the introduction of novel products contribute to the neurothrombectomy market expansion. However, the high cost of neurothrombectomy devices and the need for skilled personnel are impeding the growth of the neurothrombectomy market
A neurothrombectomy device is used to remove blood clots and retrieve clots as a therapy for ischemic stroke. Ischemic stroke occurs when a blood clot blocks blood flow to the brain, causing brain cells to die due to a lack of oxygen, resulting in stroke. Aspiration and clot retrieval devices are two types of neurothrombectomy devices.
Download PDF Brochure of Neurothrombectomy Devices Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/neurothrombectomy-devices-market/7902
Growth Drivers
Due to its rising incidence, high morbidity and mortality, and long-term psychological, physical, and social consequences, ischemic stroke at a young age is becoming a growing problem in both developing and developed countries. Stroke in young adults is more complex than stroke in older adults due to the wide range of possible underlying risk factors and etiologies. The growing prevalence of chronic diseases and lifestyle habits such as smoking, lack of exercise, etc. are responsible for ischemic stroke rising cases and driving the growth of the global neurothrombectomy devices market growth.
The global neurothrombectomy devices market has been analyzed from three different perspectives – Device type, end-user, and region.
Excerpts from ‘by Device Type’
The global neurothrombectomy devices market has been split into categories based on product type:
- Aspiration Devices
- Clot Retrievers
- Vascular Snares
Clot retrievers dominate the global neurothrombectomy market due to increased device adoption, increased investment in research and development, and the introduction of novel products. Furthermore, the rising prevalence of cardiovascular diseases and thrombophilia fuel the growth of the global neurothrombectomy devices market.
Excerpts From ‘by End User’
The global neurothrombectomy devices market has been segmented based on end-users such as:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
The hospital segment is leading the global neurothrombectomy devices market due to the need for urgent medical attention, the adoption of novel technology, and the increasing patient footfall in hospitals for diagnosis and treatment. Furthermore, favorable reimbursement policies and the rising prevalence of chronic diseases such as cardiovascular disease are driving the growth of the hospital neurothrombectomy device market.
Speak to our Analyst to Understand the Impact of COVID-19 on Your Business: https://growthplusreports.com/inquiry/speak-analyst/neurothrombectomy-devices-market/7902
Excerpts from ‘by Region Segmentation
The global neurothrombectomy devices market has been segmented into:
- North America
- Europe
- Asia Pacific
- Rest of the World
The global neurothrombectomy devices market is dominated by North America, followed by the Asia Pacific. The large share of North America in the worldwide market is attributed to the rising rate of chronic diseases, technological development, established infrastructure, and top-tier health services. Furthermore, rising healthcare expenditures, a high adoption rate of novel treatments, and favorable reimbursement policies contribute to the North American neurothrombectomy devices market growth.
Excerpts from ‘Competitive Landscape’
The prominent players operating in the global neurothrombectomy devices market are
- Acandis GmbH
- Boston Scientific Corporation
- Medtronic Plc
- MicroVention Inc.
- Penumbra, Inc.
- Phenox GmbH
- Stryker Corporation
- Vesalio
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL NEUROTHROMBECOMY MARKET - ANALYSIS & FORECAST, BY DEVICE TYPE
- Aspiration Devices
- Clot Retrievers
- Vascular Snares
- GLOBAL NEUROTHROMBECOMY MARKET - ANALYSIS & FORECAST, BY END-USER
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Directly Purchase Premium Copy of Neurothrombectomy Devices Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=pmzAHDh2VDXbl9l0St1Bcxr2ApfwUVgVau4PjP7A&report_id=7902&license=Single
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.